Methods and compositions for cancer treatment
US-2024424094-A1 · Dec 26, 2024 · US
Methods of treatment of schizophrenia
US8980252B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8980252-B2 |
| Application number | US-201214007793-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 20, 2012 |
| Priority date | Apr 21, 2011 |
| Publication date | Mar 17, 2015 |
| Grant date | Mar 17, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Described herein are compositions which include digestive enzymes and which are formulated to reduce one or more symptoms of a neuropsychiatric disorder. Also described herein is a method for treating an individual with a neuropsychiatric disorder using digestive enzymes and their derivatives to alleviate the symptoms of neuropsychiatric disorders. The method comprises administering to the individual an effective amount of digestive enzymes that are either naturally or recombinantly derived, or their derivatives, in an amount effective to reduce one or more symptoms of the neuropsychiatric disorder.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for treating schizophrenia in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of a pharmaceutical composition comprising digestive enzymes to the individual, wherein the digestive enzymes comprise a protease, an amylase and a lipase, and wherein schizophrenia is treated. 2. The method of claim 1 , wherein the individual in need thereof exhibits one or more symptom…
Assignees
Inventors
Classifications
- A61K38/465Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K38/54Primary
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8980252B2 cover?
- Described herein are compositions which include digestive enzymes and which are formulated to reduce one or more symptoms of a neuropsychiatric disorder. Also described herein is a method for treating an individual with a neuropsychiatric disorder using digestive enzymes and their derivatives to alleviate the symptoms of neuropsychiatric disorders. The method comprises administering to the indi…
- Who is the assignee on this patent?
- Fallon Joan, Heil Matthew, Szigethy James, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61K38/465. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).